Investigating Cytokine Genes of Stem Cell Donors
Cytokine Gene Polymorphisms in Allotransplant Donors
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
A observational or N/A phase clinical study on Stem Cell Transplantation, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 25 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
25 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jan 2020 — Jan 2021 [monthly]
Completed
-
Dec 2019 — Jan 2020 [monthly]
Completed
▶ Show 20 earlier versions
-
Nov 2019 — Dec 2019 [monthly]
Completed
-
Oct 2019 — Nov 2019 [monthly]
Completed
-
Sep 2019 — Oct 2019 [monthly]
Completed
-
Aug 2019 — Sep 2019 [monthly]
Completed
-
Jul 2019 — Aug 2019 [monthly]
Completed
-
Jun 2019 — Jul 2019 [monthly]
Completed
-
May 2019 — Jun 2019 [monthly]
Completed
-
Apr 2019 — May 2019 [monthly]
Completed
-
Mar 2019 — Apr 2019 [monthly]
Completed
-
Feb 2019 — Mar 2019 [monthly]
Completed
-
Jan 2019 — Feb 2019 [monthly]
Completed
-
Dec 2018 — Jan 2019 [monthly]
Completed
-
Nov 2018 — Dec 2018 [monthly]
Completed
-
Oct 2018 — Nov 2018 [monthly]
Completed
-
Sep 2018 — Oct 2018 [monthly]
Completed
-
Aug 2018 — Sep 2018 [monthly]
Completed
-
Jul 2018 — Aug 2018 [monthly]
Completed
-
Jun 2018 — Jul 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jun 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
For direct contact, visit the study record on ClinicalTrials.gov .